133 related articles for article (PubMed ID: 17197352)
1. Ultrasonographic evaluation of the change in uterine fibroids induced by treatment with a GnRH analog.
Chia CC; Huang SC; Chen SS; Kang JY; Lin JC; Lin YS; Huang KF; Lee HJ; Zheng CC
Taiwan J Obstet Gynecol; 2006 Jun; 45(2):124-8. PubMed ID: 17197352
[TBL] [Abstract][Full Text] [Related]
2. The hemodynamic effect of GnRH agonist therapy on uterine leiomyoma vascularity: a prospective study using transvaginal color Doppler sonography.
Aleem FA; Predanic M
Gynecol Endocrinol; 1995 Sep; 9(3):253-8. PubMed ID: 8540296
[TBL] [Abstract][Full Text] [Related]
3. Influence of ulipristal acetate therapy compared with uterine artery embolization on fibroid volume and vascularity indices assessed by three-dimensional ultrasound: prospective observational study.
Czuczwar P; Wozniak S; Szkodziak P; Milart P; Wozniakowska E; Wrona W; Paszkowski T
Ultrasound Obstet Gynecol; 2015 Jun; 45(6):744-50. PubMed ID: 25251811
[TBL] [Abstract][Full Text] [Related]
4. Effect of intramural fibroid on uterine and endometrial vascularity in infertile women scheduled for in-vitro fertilization.
Kamel A; El-Mazny A; Ramadan W; Abdelaziz S; Gad-Allah S; Saad H; Hussein AM; Salah E
Arch Gynecol Obstet; 2018 Feb; 297(2):539-545. PubMed ID: 29242974
[TBL] [Abstract][Full Text] [Related]
5. [A STUDY OF UTERINE HEMODYNAMICS USING THREE-DIMENSIONAL POWER DOPPLER SONOGRAPHY IN PATIENTS WITH ADENOMYOSIS].
Yakovenko K; Tamm T; Yakovenko Y
Georgian Med News; 2018 Dec; (285):21-27. PubMed ID: 30702064
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness of Doppler ultrasound in predicting the effect of gonadotropin-releasing hormone agonist (GnRHa) on myoma uteri].
Yoshioka N
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Nov; 47(11):1255-60. PubMed ID: 8543851
[TBL] [Abstract][Full Text] [Related]
7. Doppler-ultrasound as a predictor of uterine fibroid response to GnRH therapy.
Kanelopoulos N; Dendrinos S; Oikonomou A; Panagopoulos P; Markussis V
Int J Gynaecol Obstet; 2003 Jul; 82(1):41-7. PubMed ID: 12834940
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomized study to evaluate leuprolide acetate treatment before laparoscopic myomectomy: efficacy and ultrasonographic predictors.
Zullo F; Pellicano M; De Stefano R; Zupi E; Mastrantonio P
Am J Obstet Gynecol; 1998 Jan; 178(1 Pt 1):108-12. PubMed ID: 9465812
[TBL] [Abstract][Full Text] [Related]
9. Endometrial and subendometrial blood flow measured by three-dimensional power Doppler ultrasound in patients with small intramural uterine fibroids during IVF treatment.
Ng EH; Chan CC; Tang OS; Yeung WS; Ho PC
Hum Reprod; 2005 Feb; 20(2):501-6. PubMed ID: 15576392
[TBL] [Abstract][Full Text] [Related]
10. Influence of Ulipristal Acetate Therapy on Uterine Fibroid-Related Symptoms and on Uterine and Fibroid Volumes and Vascularity Indices Assessed by Ultrasound.
Baggio S; Pomini P; Galeone F; Presti F; Santi L; Raffaelli R; Franchi M
J Ultrasound Med; 2018 Sep; 37(9):2215-2223. PubMed ID: 29498074
[TBL] [Abstract][Full Text] [Related]
11. Does three-dimensional power Doppler ultrasound predict histopathological findings of uterine fibroids? A preliminary study.
Minsart AF; Ntoutoume Sima F; Vandenhoute K; Jani J; Van Pachterbeke C
Ultrasound Obstet Gynecol; 2012 Dec; 40(6):714-20. PubMed ID: 22581621
[TBL] [Abstract][Full Text] [Related]
12. Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Buserelin.
Matta WH; Stabile I; Shaw RW; Campbell S
Fertil Steril; 1988 Jun; 49(6):1083-5. PubMed ID: 2967195
[TBL] [Abstract][Full Text] [Related]
13. The use of 3D power Doppler ultrasound in the quantification of blood vessels in uterine fibroids: feasibility and reproducibility.
Nieuwenhuis LL; Betjes HE; Hehenkamp WJ; Heymans MW; Brolmann HA; Huirne JA
J Clin Ultrasound; 2015 Mar; 43(3):171-8. PubMed ID: 25111971
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of single-dose gonadotropin-releasing hormone agonist administration prior to magnetic resonance-guided focused ultrasound surgery for symptomatic uterine fibroids.
Park H; Yoon SW
Radiol Med; 2017 Aug; 122(8):611-616. PubMed ID: 28341966
[TBL] [Abstract][Full Text] [Related]
15. The assessment of benign uterine tumor vascularization by transvaginal color Doppler.
Kurjak A; Kupesic-Urek S; Miric D
Ultrasound Med Biol; 1992; 18(6-7):645-9. PubMed ID: 1413276
[TBL] [Abstract][Full Text] [Related]
16. The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids: a meta-analysis.
Zhang Y; Sun L; Guo Y; Cheng J; Wang Y; Fan S; Duan H
Obstet Gynecol Surv; 2014 Feb; 69(2):100-8. PubMed ID: 25112488
[TBL] [Abstract][Full Text] [Related]
17. 3D power Doppler in uterine fibroids; influence of gain, cardiac cycle and off-line measurement techniques.
Nieuwenhuis LL; Hehenkamp WJK; Brölmann HAM; Huirne JAF
J Obstet Gynaecol; 2018 Jan; 38(1):103-109. PubMed ID: 28780884
[TBL] [Abstract][Full Text] [Related]
18. Treatment of uterine fibroids with agonist analogs of gonadotropin-releasing hormone.
Kessel B; Liu J; Mortola J; Berga S; Yen SS
Fertil Steril; 1988 Mar; 49(3):538-41. PubMed ID: 3277869
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional power Doppler study of changes in uterine vascularity after absorbable cervical tourniquet during open myomectomy.
El Behery MM; Zaitoun MM; Siam S; Ibraheim MA
Arch Gynecol Obstet; 2011 Jul; 284(1):157-61. PubMed ID: 20700742
[TBL] [Abstract][Full Text] [Related]
20. Reduction in the vascular bed volume of uterine fibroids after hormonal treatment: evaluation with dynamic double-echo R₂* imaging.
Okuda S; Oshio K; Asada H; Tanimoto A; Jinzaki M; Furuya M; Yoshimura Y; Kuribayashi S
Magn Reson Med Sci; 2012; 11(4):283-9. PubMed ID: 23269015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
